Is Tyra Biosciences, Inc. profitable?

Tyra Biosciences, Inc. is not currently profitable: it reported a net loss of $131.1M over the trailing twelve months.

What is Tyra Biosciences, Inc.'s earnings per share?

Tyra Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-2.17.

Where does Tyra Biosciences, Inc.'s income statement data come from?

Every line is extracted from Tyra Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Tyra Biosciences, Inc. TYRA Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Research and development	$33.47M+18.7%	$28.19M+10.7%	$25.47M+4.8%	$24.31M-2.6%	$24.96M+12.6%
General and administrative	$8.53M+2.4%	$8.33M+11.4%	$7.48M+4.6%	$7.14M+3.7%	$6.89M-9.0%
Other operating expenses	$42M+15.0%	$36.52M+10.8%	$32.94M+4.7%	$31.45M-1.2%	$31.85M+7.1%
Total operating expenses	$42M+15.0%	$36.52M+10.8%	$32.94M+4.7%	$31.45M-1.2%	$31.85M+7.1%
Operating income	-$42M-15.0%	-$36.52M-10.8%	-$32.94M-4.7%	-$31.45M+1.2%	-$31.85M-7.1%
Interest income	$2.69M+0.4%	$2.68M-12.8%	$3.08M-8.3%	$3.35M-9.4%	$3.7M-11.3%
Other income (expense), net	$2.69M+0.4%	$2.68M-12.8%	$3.08M-8.3%	$3.35M-9.4%	$3.7M-11.3%
Net income	-$39.31M-16.2%	-$33.83M-13.3%	-$29.87M-6.3%	-$28.1M+0.2%	-$28.15M-10.1%
Diluted earnings per share	-$0.64-14.3%	-$0.56-12.0%	-$0.50-6.4%	-$0.470.0%	-$0.47-9.3%
Basic earnings per share	-$0.64-14.3%	-$0.56-12.0%	-$0.50-6.4%	-$0.470.0%	-$0.47-9.3%
Weighted-average shares, diluted	61.7M+3.6%	59.6M-0.1%	59.7M+0.2%	59.6M+0.4%	59.3M+3.7%
Weighted-average shares, basic	61.7M+3.6%	59.6M-0.1%	59.7M+0.2%	59.6M+0.4%	59.3M+3.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	-$39.59M-16.8%	-$33.88M-13.5%	-$29.86M-5.3%	-$28.35M-0.4%	-$28.23M-6.3%
Interest income and other, net	$2.69M+0.4%	$2.68M-12.8%	$3.08M-8.3%	$3.35M-9.4%	$3.7M-11.3%
EBIT	-$42M-15.0%	-$36.52M-10.8%	-$32.94M-4.7%	-$31.45M+1.2%	-$31.85M-7.1%
EBITDA	-$41.86M-15.1%	-$36.38M-10.9%	-$32.81M-4.8%	-$31.31M+1.2%	-$31.71M-7.1%
EBITDA	-$41.86M-15.1%	-$36.38M-10.9%	-$32.81M-4.8%	-$31.31M+1.2%	-$31.71M-7.1%
EBIT	-$42M-15.0%	-$36.52M-10.8%	-$32.94M-4.7%	-$31.45M+1.2%	-$31.85M-7.1%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Is Tyra Biosciences, Inc. profitable?: Tyra Biosciences, Inc. is not currently profitable: it reported a net loss of $131.1M over the trailing twelve months.
What is Tyra Biosciences, Inc.'s earnings per share?: Tyra Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-2.17.
Where does Tyra Biosciences, Inc.'s income statement data come from?: Every line is extracted from Tyra Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.